Ownership history in Pier Capital, LLC · 12 quarters on record
This page tracks every 13F SEC filing in which Pier Capital, LLC reported a position in Roivant Sciences Ltd (ROIV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 391,061 | -3,623 | -0.9% | 1.35% | $8.5M | $21.70 |
| 2025 Q3 | REDUCED | 394,684 | -1,620 | -0.4% | 0.93% | $6.0M | $15.13 |
| 2025 Q2 | REDUCED | 396,304 | -31,839 | -7.4% | 0.68% | $4.5M | $11.27 |
| 2025 Q1 | ADDED | 428,143 | +5,413 | +1.3% | 0.72% | $4.3M | $10.09 |
| 2024 Q4 | REDUCED | 422,730 | -7,178 | -1.7% | 0.71% | $5.0M | $11.83 |
| 2024 Q3 | ADDED | 429,908 | +4,821 | +1.1% | 0.70% | $5.0M | $11.54 |
| 2024 Q2 | ADDED | 425,087 | +96,905 | +29.5% | 0.67% | $4.5M | $10.57 |
| 2024 Q1 | REDUCED | 328,182 | -3,085 | -0.9% | 0.48% | $3.5M | $10.54 |
| 2023 Q4 | REDUCED | 331,267 | -3,736 | -1.1% | 0.53% | $3.7M | $11.23 |
| 2023 Q3 | REDUCED | 335,003 | -279,932 | -45.5% | 0.63% | $3.9M | $11.68 |
As of 2025 Q4 — sorted by position size